CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

BioNTech taps Sobi executive Oelkers as its next CEO

Neutral
AI Analysis

Summary

BioNTech appoints Guido Oelkers, an executive from Sobi, as its next CEO to lead the company's transition toward oncology focus, while co-founder Ugur Sahin departs to lead an mRNA startup.

Importance:3/10
Sentiment:
0.00
leadership_changeCEO_appointmentoncology_focusmanagement_transition
Related Companies

Read the original article

Published by BioPharma Dive on August 3, 2026 3:49 PM

Read Original